Meyer Handelman Company’s GSK GSK Stock Holding History

Meyer Handelman Company’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$885K	Sell	16,027 -1,305	-8%	-$70.7K	0.03%	167
2025 Q4	$850K	Sell	17,332 -880	-5%	-$41K	0.03%	166
2025 Q3	$786K	Sell	18,212 -640	-3%	-$25K	0.02%	164
2025 Q2	$724K	Buy	18,852 +795	+4%	+$30.4K	0.02%	166
2025 Q1	$700K	Sell	18,057 -960	-5%	-$35.1K	0.02%	167
2024 Q4	$643K	Sell	19,017 -4,570	-19%	-$165K	0.02%	173
2024 Q3	$964K	Hold	23,587	–	–	0.03%	159
2024 Q2	$908K	Hold	23,587	–	–	0.03%	157
2024 Q1	$1.01M	Hold	23,587	–	–	0.04%	158
2023 Q4	$874K	Hold	23,587	–	–	0.03%	154
2023 Q3	$855K	Hold	23,587	–	–	0.03%	154
2023 Q2	$841K	Sell	23,587 -1,200	-5%	-$43K	0.03%	152
2023 Q1	$882K	Sell	24,787 -4,803	-16%	-$168K	0.04%	151
2022 Q4	$1.04M	Sell	29,590 -1,880	-6%	-$62.6K	0.04%	143
2022 Q3	$926K	Sell	31,470 -1,920	-6%	-$72.8K	0.04%	146
2022 Q2	$1.82M	Hold	33,390	–	–	0.08%	129
2022 Q1	$1.82M	Sell	33,390 -2,913	-8%	-$158K	0.07%	129
2021 Q4	$2M	Hold	36,303	–	–	0.07%	127
2021 Q3	$1.73M	Hold	36,303	–	–	0.07%	130
2021 Q2	$1.81M	Hold	36,303	–	–	0.07%	132
2021 Q1	$1.62M	Buy	36,303 +4,403	+14%	+$200K	0.07%	130
2020 Q4	$1.47M	Sell	31,900 -1,445	-4%	-$66.4K	0.07%	127
2020 Q3	$1.57M	Hold	33,345	–	–	0.08%	122
2020 Q2	$1.7M	Hold	33,345	–	–	0.09%	117
2020 Q1	$1.58M	Sell	33,345 -962	-3%	-$51.3K	0.1%	116
2019 Q4	$2.02M	Sell	34,307 -1,200	-3%	-$66.8K	0.1%	120
2019 Q3	$1.89M	Hold	35,507	–	–	0.1%	121
2019 Q2	$1.78M	Hold	35,507	–	–	0.09%	123
2019 Q1	$1.78M	Sell	35,507 -1,600	-4%	-$80K	0.09%	122
2018 Q4	$1.77M	Hold	37,107	–	–	0.1%	119
2018 Q3	$1.86M	Sell	37,107 -3,642	-9%	-$185K	0.09%	123
2018 Q2	$2.05M	Sell	40,749 -3,873	-9%	-$195K	0.11%	121
2018 Q1	$2.18M	Sell	44,622 -3,200	-7%	-$149K	0.11%	122
2017 Q4	$2.12M	Buy	47,822 +1,040	+2%	+$48K	0.1%	123
2017 Q3	$2.37M	Hold	46,782	–	–	0.11%	120
2017 Q2	$2.52M	Hold	46,782	–	–	0.11%	120
2017 Q1	$2.46M	Buy	46,782 +160	+0.3%	+$8.12K	0.11%	120
2016 Q4	$2.24M	Hold	46,622	–	–	0.1%	121
2016 Q3	$2.51M	Hold	46,622	–	–	0.11%	115
2016 Q2	$2.53M	Sell	46,622 -532	-1%	-$28K	0.11%	115
2016 Q1	$2.39M	Sell	47,154 -728	-2%	-$36.3K	0.11%	115
2015 Q4	$2.42M	Buy	47,882 +320	+0.7%	+$16.3K	0.11%	118
2015 Q3	$2.29M	Buy	47,562 +320	+0.7%	+$16.7K	0.12%	118
2015 Q2	$2.46M	Hold	47,242	–	–	0.11%	117
2015 Q1	$2.73M	Buy	47,242 +3,040	+7%	+$174K	0.12%	113
2014 Q4	$2.36M	Buy	44,202 +640	+1%	+$35.8K	0.11%	116
2014 Q3	$2.5M	Buy	43,562 +1,200	+3%	+$73.6K	0.12%	113
2014 Q2	$2.83M	Buy	42,362 +120	+0.3%	+$8.12K	0.13%	107
2014 Q1	$2.82M	Sell	42,242 -533	-1%	-$36K	0.14%	107
2013 Q4	$2.85M	Buy	42,775 +1,600	+4%	+$104K	0.14%	109
2013 Q3	$2.58M	Hold	41,175	–	–	0.14%	105
2013 Q2	$2.57M	Buy	+41,175	New	+$2.61M	0.14%	105

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Meyer Handelman Company's GSK Position: Q1 2026 in Review

Meyer Handelman Company reduced its GSK (GSK) stake by 7.5% in Q1 2026, selling an estimated $70.7K and leaving 16,027 shares worth $885K. The position accounts for 0.03% of the portfolio, ranked #167.

Meyer Handelman Company first reported a position in GSK in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.85M in Q4 2013. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Meyer Handelman Company held 16,027 shares of GSK worth $885K as of Q1 2026.
Meyer Handelman Company sold 1,305 GSK shares in Q1 2026, an estimated $70.7K.
GSK made up 0.03% of Meyer Handelman Company's portfolio in Q1 2026, its #167 holding.
Meyer Handelman Company first reported a position in GSK in Q2 2013 and has held it in 52 quarters since.
Meyer Handelman Company's GSK position peaked at $2.85M in Q4 2013.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Meyer Handelman Company's 13F filing for Q1 2026, filed 20 Apr 2026.